$450.00+1.42%Close 13 Nov 2026 · Market value $54.77B
About Humana
Humana Inc., headquartered in Louisville, Kentucky, operates two reportable segments: Insurance and CenterWell. The Insurance segment offers Medicare Advantage, stand-alone Medicare prescription drug plans, Medicaid state-based contracts, individual and employer specialty products such as dental, vision, life and disability, and a pharmacy benefit manager business. It also administers TRICARE contracts for military personnel and their dependents. The CenterWell segment provides pharmacy solutions, senior-focused primary care clinics, and home health and home solutions. Customers include members enrolled through government programs and employer groups, and 83% of 2025 premiums and services revenue came from federal government contracts. The company has a national Medicare presence in all 50 states and operates Medicaid contracts in multiple states.
A summary of the business section of the company's latest annual report, filed 19 Feb 2026.
Company facts
| Ticker | HUM · NYSE |
|---|
| Sector | Insurance |
|---|
| Industry | Managed Health Care |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 49071 |
|---|
| Latest annual report | 10-K, filed 19 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| James A. Rechtin | President & CEO | 44.3K | Grant or award, 1 May 2026 |
|---|
| Susan M. Diamond | Chief Financial Officer | 41.7K | Shares withheld for tax, 15 Dec 2024 |
|---|
| Sanjay K. Shetty, M.D. | President, CenterWell | 9.1K | Grant or award, 1 May 2026 |
|---|
| Celeste M. Mellet | Chief Financial Officer | 8.7K | Grant or award, 1 May 2026 |
|---|
| Jorge S. Mesquita | Director | 3.4K | Grant or award, 2 Jan 2026 |
|---|
| Japan A. Mehta | Chief Information Officer | 2.4K | Grant or award, 1 May 2026 |
|---|
| Michelle A. O’Hara | Chief Human Resources Officer | 769 | Grant or award, 1 May 2026 |
|---|
| Gordon Smith | Director | 765 | Option exercise, 1 Nov 2025 |
|---|
| David T. Feinberg, M.D. | Director | 441 | Grant or award, 2 Jan 2026 |
|---|
| Wayne A.I. Frederick, M.D. | Director | 440 | Open-market sale, 10 Nov 2026 |
|---|
| Dintenfass David | President, Enterprise Growth | — | Gift, 10 Nov 2026 |
|---|
| Ventura Joseph C | Chief Legal Officer | — | Open-market sale, 9 Nov 2026 |
|---|
| Nundy Shantanu | Chief Medical Officer | — | Grant or award, 1 Sep 2026 |
|---|
| Smith Paul John | Director | — | Grant or award, 1 Aug 2026 |
|---|
| Crawford Frederick John | Director | — | Grant or award, 1 Aug 2026 |
|---|
| Field Robert Stuart | Director | — | Grant or award, 1 May 2026 |
|---|
| Martin Aaron | President, Medicare Advantage | — | Grant or award, 1 May 2026 |
|---|
| Renaudin George II | President, Insurance | — | Option exercise, 24 Feb 2026 |
|---|
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. | — | Option exercise, 24 Feb 2026 |
|---|
| Agrawal Vishal | Chief Strat & Corp Dev Officer | — | Grant or award, 24 Feb 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
HUM in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.